Advances in genome sequencing, genomic editing and induced pluripotent stem cells will revolutionize the practice of medicine, NIH Director Francis Collins says in this in-depth interview. For example, iPS cells could be used not only to study a particular patient's disease but also to develop personalized treatments, he says. Basic science supported by the NIH will help scientists develop algorithms to analyze complicated DNA and RNA sequences and translate the information into therapies, he says.
NIH director discusses the $1,000 genome, basic science
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|